Authors: JUNQUERO D OMS P GOTTELAND JP DEGRYSE AD HALAZY S DELHON A

Citation: D. Junquero et al., LIPID-REGULATING EFFECTS OF NEW CLASSES OF SQUALENE EPOXIDASE INHIBITORS, Atherosclerosis, 134(1-2), 1997, pp. 126-126

Authors: GOTTELAND JP JUNQUERO D OMS P DELHON A HALAZY S

Citation: Jp. Gotteland et al., COMPARATIVE-STUDY OF NEW AND KNOWN THIENYL DERIVATIVES OF ENE-YNE BENZYLAMINE AS MAMMALIAN SQUALENE EPOXIDASE INHIBITORS, Medicinal chemistry research, 6(5), 1996, pp. 333-342

Authors: GOTTELAND JP DELHON A JUNQUERO D OMS P HALAZY S

Citation: Jp. Gotteland et al., DESIGN AND SYNTHESIS OF NEW HYPOCHOLESTEROLEMIC ORGANOSILANES WITH ANTIOXIDANT PROPERTIES, Bioorganic & medicinal chemistry letters, 6(5), 1996, pp. 533-538

Authors: OMS P ASSIE N BRUNIQUEL F DEGRYSE AD VANHAVERBEKE G DELHON A

Citation: P. Oms et al., BIOCHEMICAL-CHANGES AND MORPHOLOGICAL ALTERATIONS OF LIVER AND KIDNEYIN HAMSTERS AFTER ADMINISTRATION OF THE HMG-COENZYME-A REDUCTASE INHIBITOR, SIMVASTATIN - PREVENTION AND REVERSIBILITY BY MEVALONATE, Pharmacology & toxicology, 77(6), 1995, pp. 391-396

Authors: GOTTELAND JP BRUNEL I GENDRE F DESIRE J DELHON A JUNQUERO D OMS P HALAZY S

Citation: Jp. Gotteland et al., (ARYLOXY)METHYLSILANE DERIVATIVES AS NEW CHOLESTEROL-BIOSYNTHESIS INHIBITORS - SYNTHESIS AND HYPOCHOLESTEROLEMIC ACTIVITY OF A NEW CLASS OFSQUALENE EPOXIDASE INHIBITORS, Journal of medicinal chemistry, 38(17), 1995, pp. 3207-3216